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Activated caspase-3In mice lacking functional brain-derived neurotrophic factor (BDNF), the number of geniculate ganglion
neurons, which innervate taste buds, is reduced by one-half. Here, we determined how and when BDNF
regulates the number of neurons in the developing geniculate ganglion. The loss of geniculate neurons begins
at embryonic day 13.5 (E13.5) and continues until E18.5 in BDNF-null mice. Neuronal loss in BDNF-null mice
was prevented by the removal of the pro-apoptotic gene Bax. Thus, BDNF regulates embryonic geniculate
neuronal number by preventing cell death rather than promoting cell proliferation. The number of
neuroﬁlament positive neurons expressing activated caspase-3 increased on E13.5 in bdnf−/− mice,
compared to wild-type mice, demonstrating that differentiated neurons were dying. The axons of geniculate
neurons approach their target cells, the fungiform papillae, beginning on E13.5, at which time we found
robust BDNFLacZ expression in these targets. Altogether, our ﬁndings establish that BDNF produced in
peripheral target cells regulates the survival of early geniculate neurons by inhibiting cell death of
differentiated neurons on E13.5 of development. Thus, BDNF acts as a classic target-derived growth factor in
the developing taste system.).
ll rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
A small cranial sensory ganglion called the geniculate ganglion
innervates chemosensory receptors responsible for the sense of taste
that are on the front two-thirds of the tongue, the soft palate and the
nasoincisor ducts of the hard palate. These neurons carry information
from peripheral chemosensory cells to the central nervous system.
The development of peripheral circuitry in the taste system is highly
regulated, in that each taste bud is innervated by a speciﬁc number of
neurons (Krimm and Hill, 1998; Zaidi and Whitehead, 2006). The
mechanisms underlying this numerical precision are unclear, but the
ﬁnal number of taste neurons available to innervate each taste bud is
determined by the relative contributions of cell proliferation, differ-
entiation, and cell death within the geniculate ganglion during devel-
opment. Early in geniculate ganglion development, cells are added
rapidly (Altman and Bayer, 1982). By embryonic day 14.5 (E14.5) in
rat (around E12.5–E13 in mouse), cell proliferation has slowed and
thereafter the total number of neurons remains constant throughout
the embryonic period (Carr et al., 2005). Like most regions of the
nervous system, the geniculate ganglion overproduces neurons and
undergoes a period of cell death, the peak of which is approximately
E16.5 in rat (approximately E14–E14.5 in mouse) (Carr et al., 2005).
However, total neuron number doesn't change after E13.5 in rat indi-
cating that neuronal proliferation and differentiation progress at equiv-alent rates throughout much of embryonic development (Carr et al.,
2005).Ahost of factors includingneurotrophins likely regulate neuronal
proliferation, differentiation, and death in the geniculate ganglion.
Inmammals, the neurotrophin family consists of nerve growth fac-
tor (NGF), brain-derived neurotrophic factor (BDNF), neurotrophin-3
(NT3), and neurotrophin-4 (NT-4) (Huang and Reichardt, 2001).
These neurotrophins are sometimes thought to be produced by pe-
ripheral target tissues, where they inﬂuence neuron number by pre-
venting the death of ganglion neurons that innervate them (Huang
and Reichardt, 2001; Vogel and Davies, 1991). Alternatively, they are
sometimes expressed within sensory ganglia and along projection
pathways where they inﬂuence neuron development before target
innervation (Farinas et al., 1996). Neurotrophins not only regulate
neuronal numbers by inﬂuencing survival of differentiated neurons,
but can also inﬂuence survival, differentiation, and proliferation of
neuronal precursors during early development (Ernfors, 2001; Farinas
et al., 2002; Liebl et al., 2000; Lopez-Sanchez and Frade, 2002).
The ﬁnal number of neurons that comprise the geniculate ganglion
is inﬂuenced by BDNF. Relative to wild-type animals, bdnf−/− mice
show a signiﬁcant reduction in neurons in the geniculate ganglion by
birth (Conover et al., 1995; Liu et al., 1995). Approximately 45–65% of
the taste buds on the anterior tongue, whose survival requires gus-
tatory innervation, are also lost in bdnf−/−mice (Mistretta et al., 1999;
Nosrat et al., 1997; Sun and Oakley, 2002), indicating that many of the
missing neurons are gustatory. The mechanism employed by BDNF
during embryogenesis to inﬂuence the neuronal numbers within
the adult geniculate ganglion is unknown. Since BDNF is expressed
in the geniculate ganglion, tongue muscle, and gustatory targets of
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Olson, 1995; Schecterson and Bothwell, 1992), the removal of BDNF
frommultiple locations, at any embryonic age and through a variety of
mechanisms could result in a reduction of geniculate neurons.
In this study, we sought to determine how and when BDNF regu-
lates the ﬁnal number of sensory neurons that comprise the geniculate
ganglion.We established that BDNF expressed in taste epitheliumpro-
motes survival of differentiated gustatory neurons as they ﬁrst inner-
vate their targets, before the peak of naturally occurring cell death.
Materials and methods
Animals
All BDNF mutant (bdnf−/−) and wild-type mice were on a C57BL/
6J background strain. Homozygous bdnf−/− embryos were obtained
by breeding mice with heterozygous targeted mutations of the bdnf
gene. Heterozygous bdnf−/+ mice were acquired from Jackson
Laboratories (Bar Harbor, Maine, USA; #002266). Animals were
genotyped by polymerase chain reaction, as described in protocols
provided by Jackson Laboratories, http://jaxmice.jax.org/). Bdnf-
lacZ mice were a kind gift from Kevin Jones (Dept. of Molecular,
Cellular and Developmental Biology, University of Colorado at
Boulder, Boulder, CO, USA) (Baquet et al., 2005; Gorski et al.,
2003a,b). Bdnf-lacZ mice have been used successfully to examine
BDNF-producing locations in the adult taste system (Yee et al.,
2003). Animals were genotyped by polymerase chain reaction using
the lacZ forward primer 5′-TTC ACT GGC CGT CGT TTT ACA ACG TCG
TGA-3′, and the lacZ reverse primer 5′-ATG TGA GCG AGT AAC AAC
CCG TCG GAT TCT-3′. Embryonic mice were obtained from time-
bred females that were placed with males just before the 8-h dark
period and examined for plugs the following morning. The day a
plug was observed was designated embryonic day 0.5 (E0.5). Heads
from wild-type, bdnf−/−, bax−/−, and bdnf−/−/bax−/− double
knockout mice at birth were a kind gift from David M. Katz (Dept. of
Neurosciences, CaseWestern Reserve University, Cleveland, OH, USA).
Single-label immunohistochemistry
Embryos aged 14.5 (E14.5) and older were immediately perfused
using chilled 4% paraformaldehyde (PFA), and animals E13.5 and
younger were ﬁxed by immersion in PFA. All embryos were ﬁxed
overnight in 4% PFA. Following ﬁxation, embryo heads were moved to
70% ethanol and processed for parafﬁn embedding. Immuno-detection
of the cytoskeletal element class III β-tubulin (β-III tubulin) was used
to visualize geniculate ganglion neurons. Serial transverse sections
(5 μm) of parafﬁn-embedded embryo heads were collected on Fischer
SuperFrost/Plus slides (Fisher Scientiﬁc, Pittsburgh, PA, USA). Parafﬁn
was removed by immersion in CitriSolv (Fisher). Sectioned tissues
were rehydrated in a graded series of alcohols, followed by 0.1 M
phosphate-buffer saline (PBS), pH 7.4. Endogenous peroxidase activity
was quenched by treatment for 15 min in a solution of 10%methanol/
3% H2O2 in PBS. Slides were washed in dH2O (3×5 min each). In the
antigen retrieval step that followed, slides were boiled in the micro-
wave for 5×2 min in citrate buffer (0.1 M citric acid/0.1 M Na citrate/
dH2O; pH 6) with a 5 min rest between the two boiling periods, and
then cooled down to room temperature. The sections were washed in
PBS and blocked for 30 min in blocking buffer (PBS/5% goat serum/
0.25% Triton X-100) and were then incubated overnight at 4 °C in
blocking buffer containing a 1:1000 dilution of monoclonal mouse
anti-β-III tubulin antibody (TUJ1; Covance, Princeton, NJ, USA; catalog
# MMS-435P). On the following day, the sections were washed in PBS
(3×5 min) and incubated for 2 h at room temperature in blocking
buffer containing a 1:200 dilution of biotinylated anti-mouse sec-
ondary antibody (Vector Laboratories, Burlingame, CA, USA; #BA-
2000), and visualized with an ABC diaminobenzidine reaction. Thefollowing numbers of mice embryos were used for quantiﬁcation:
wild-type (n=3forE12.5, E14.5, E16.5, E18.5;n=5forE13.5);bdnf−/−
(n=3 for E12.5, E13.5, E16.5, E18.5; n=4 for E14.5).
Triple-label immunohistochemistry
Pregnant females were injected 2 h before sacriﬁce with 50 mg/kg
(intraperitoneal) of 2′-bromo-5′-deoxyuridine (BrdU; 5 ml/kg of a
10 mg/ml stock solution in 0.1 M Tris–HCl buffer, pH 7.5). Embryos
were immersion-ﬁxed overnight in 4% PFA in PBS, pH 7.4. They were
then placed in 30% sucrose/PBS overnight for cryoprotection, and fro-
zen on dry ice in OCT embedding medium. Embedded embryo heads
were sectioned transversely (16-μm), mounted on SuperFrost/Plus
slides (Fisher), and allowed to air-dry. Fixed, mounted transverse
sections were treated with 2 N HCl and heated to 37 °C for 30 min.
Slides were washed in dH2O (3×5 min each). In the antigen retrieval
step that followed, slides were boiled for 15 min in citrate buffer
(0.1 M citric acid/0.1 M Na citrate/dH2O; pH 6), and allowed to cool
down to room temperature. Next, the slides were washed in PBS
(3×5 min) and blocked in blocking buffer (described above) for
30 min. Sections were incubated overnight in the following primary
antibodies: anti-BrdU (1:200, Accurate Chemicals,Westbury, NY, USA;
#OBT0030), mouse anti-neuroﬁlament (1:200, Millipore, Billerica,
MA, USA; #MAB5266), and rabbit anti-cleaved caspase-3 (Asp175)
(1:200, Cell Signaling, Beverly, MA, USA; #9661). The slides were
washed in PBS (3×5 min), and then incubated for 2 h at room
temperature in the following secondary antibodies: alexa-488 anti-rat
(A11006), alexa-546 anti-mouse (A11030), and alexa-647 anti-rabbit
(A21244;Invitrogen, Carlsbad, CA, USA) at a dilution of 1:200 in
blocking buffer. Slides were dehydrated in a graded series of alcohols
and cover slipped in CitriSolv with DPX mounting medium (Sigma-
Aldrich, St. Louis, MO, USA). Immuno-labeled tissue was visualized
using a ﬂuorescence confocal microscope. Antigen-positive cells were
quantiﬁed from n=3 each wild-type and bdnf−/− embryos.
β-Galactosidase histochemistry
Detection of β-Gal was performed either in whole mount embryo
tissue or in both sagittal and transverse sections. The embryos were
immersion-ﬁxed in ice cold 0.5% glutaraldehyde in PBS/MgCl2 solu-
tion (2 mMMgCl2 in PBS) for 1–2 h. Fixative was removed bymultiple
washes in ice cold PBS/MgCl2 and embryos were frozen on Dry Ice in
OCT embedding medium. Tissue sections (25 µm) were mounted on
SuperFrost/Plus slides and allowed to air-dry for 1 h at 4 °C. Whole
mount tissues and sections were washed in ice cold PBS/MgCl2 to
thoroughly remove OCT and then immersed in X-gal staining solution
(InvivoGen, San Diego, CA; 0.02% Igepal, 0.01% sodium deoxycholate,
5 mM potassium ferrocyanide, 5 mM potassium ferricyanide, and
1 mg/ml X-gal in PBS/MgCl2) for 2–6 h in a 37 °C incubator. Tissues
were then washed and photographed. For immunohistochemistry fol-
lowing X-gal staining, sections were ﬁxed for 1 h in ice cold 4%
PFA. Slides were washed in PBS and were allowed to dry on a 37 °C
heater overnight. β-Gal-stained tissue was labeled with mouse anti-
neuroﬁlament antibody using the single-label immunohistochem-
istry protocol described above. Sections were mounted in Glycergel
mounting medium (Dako North America, Carpinteria, CA, USA) and
imaged using a bright ﬁeld camera.
Quantiﬁcation of β-III tubulin geniculate ganglion neurons
Neurons of the geniculate ganglion were quantiﬁed in transverse
serial sections of the mouse embryo head. Monoclonal mouse anti-β-
III tubulin antibody (TUJ-1) was used to identify and count neuron
proﬁles, only in sections where the nucleus was visible (“*” Fig. 2J
inset). Neuronal proﬁles were counted in six sections per geniculate
ganglion. The area containing the geniculate ganglion was measured
Fig. 1. Even at the early age of E12.5 the geniculate ganglion can be positively identiﬁed
for quantiﬁcation. Early in development, E13.5 and earlier, the geniculate ganglion is
“fused” with the acoustic/vestibular ganglion. However, TUJ-1 labeled transverse
sections reveal that although these two ganglia are adjacent, the geniculate ganglion
(enclosed by a dashed black line) is identiﬁable as a structure distinct from the acoustic
vestibular ganglion. Scale bar=25 µm.
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derive the volume. The volumes for all sections were summed to
derive the volume for the entire ganglion. The total number of neuron
proﬁles in the ganglion was estimated as the product: (number of
proﬁles per volume of the counted section)×(total volume of the
entire ganglion). The total number of neurons per ganglion was esti-
mated by multiplying the number of total neuron proﬁles by a correc-
tion factor, to compensate for the presence of the nucleus in multiple
sections (Abercrombie, 1946), according to the formula: N=n×[T/
(T×D)] where N is the estimated total number of neurons, n is the
number of nuclear proﬁles, T is the measured section thickness, and D
is the average diameter of nuclei. This estimate was calculated sepa-
rately for each ganglion based on the average diameter of 50 neuronal
nuclei. Diameters were calculated from area measurements of each
nucleus. This approach has been used successfully to examine changes
in ganglion neuron number followingmanipulations of neurotrophins
(Agerman et al., 2003; ElShamy and Ernfors, 1997; Erickson et al.,
2001, 1996).
Stereology
Time-bred mouse embryos at E13.5 (wild-type, n=3; bdnf−/−,
n=3) were euthanized and immersion-ﬁxed in 4% PFA in 0.1 M PBS
(pH 7.4), and transferred to 30% sucrose until the tissue sank to the
bottom of the jar. Heads were then transferred to a 1:1 mixture of 30%
sucrose:OCT, and allowed to equilibrate for 1–2 h. Subsequently, the
heads were frozen in OCT embedding medium and stored at−80 °C.
Double knockouts for bdnf and the pro-apoptotic gene bax were a
gift from Dr. D.M. Katz (Department of Neurosciences, Case Western
Reserve University, Cleveland, OH). Embryo heads were cut in trans-
verse serial sections (60 μm), air dried on a slide warmer for 3 h,
and stained with cresyl violet. To maintain section thickness, tissues
were not dehydrated andweremounted in a glycerol-basedmounting
medium for stereological quantiﬁcation. Neurons were quantiﬁed
using Stereo Investigator (version 7) software (MBF Bioscience,
Williston, VT, USA). An experimenter blinded to the genotype of
the animals traced a contour around the geniculate ganglionunder low
magniﬁcation (20×). Every section containing the ganglionwas traced
for a volumemeasurement, and cells were quantiﬁed in three of those
sections. Counting parameterswere optimized such that a sample of at
least 300 cells was counted. Within each traced contour of the
geniculate ganglion, the computer determined the placement of the
counting frames randomly. The depth (z-axis) of the counting frame
was equal tominimal thickness of the section,minus a total guard zone
of 6 µm (3 µm from the top and bottom of the section). At 100×
magniﬁcation, geniculate ganglion neurons were counted in the
volume designated by each counting frame (25 µm2). Cells were
counted only when they ﬁrst came into focus (cell top), so that each
cell was counted only once. Based on these measurements, the total
volume of the ganglion was estimated using the Cavalieri method
(MBF Bioscience), and the total number of cells then estimated for the
entire volume of the ganglion using the optical fractionator probe
(MBF Bioscience).
Data analysis
Geniculate ganglion cell numbers were quantiﬁed as mentioned
above. Total neuron number and total volume were compared be-
tween genotypes on embryonic days E12.5, E13.5, E14.5, E16.5, and
E18.5, using a two-way analysis of variance (ANOVA). The cell death
data was analyzed using two-way repeated measures ANOVA (one
factor repetition). The Bax experiment data was analyzed using a one
way ANOVA. Bonferroni's post hoc test was used to compare indi-
vidual means as needed. The signiﬁcance level was set at pb0.05 for
all statistical comparisons.Results
Lack of BDNF causes a decrease in the number of geniculate ganglion
neurons between E12.5 and E13.5 of development
To understand the timing of the geniculate ganglion neuronal reduc-
tion seen at birth in bdnf−/− mice, we quantiﬁed the number of genic-
ulate neurons from E12.5 until E18.5 for both wild-type and bdnf−/−
mice. Neuronal cells were identiﬁed using a neuron-speciﬁc anti-β-III
tubulin antibody (TUJ-1), which labels only neurons and neuronal pre-
cursors (Fanarraga et al., 1999). The geniculate ganglion was easily
recognizable as adistinct entity, even though it is fusedwith the acoustic/
vestibular ganglion at ages E13.5 and earlier (Fig. 1) TUJ-1-labeled cells
are easily recognized by their dark stained cytoplasm and a clear nucleus
(Fig. 2J insert, asterisk). Overall, there was a signiﬁcant decrease in the
number of neuronswith embryonic age (pb0.001). Inwild-typemice the
number of ganglion neurons did not differ between ages E12.5, E13.5 and
E14.5, but at E16.5 the neuronal number was reduced by 36% relative to
E12.5 (pb0.05, Fig. 3A). There was also a substantial decrease in neuron
number in bdnf−/− mice compared with wild-type mice (pb0.001),
which was age dependent. Speciﬁcally, there was no difference between
wild-type and bdnf−/− embryos in the total number of geniculate gan-
glion neurons at E12.5. However, by embryonic day E13.5 the number of
neurons in geniculate ganglia of bdnf−/− embryos was reduced by 32%
relative towild-type embryos (pb0.01, Fig. 3A). The neuron loss at E13.5
was veriﬁed using a stereological Optical Fractionator counting method
(Fig. 3B). This approach is considered more reliable than the immuno-
histochemical approach, in that fewer assumptions are made about the
tissue. However, it also has the disadvantage in that the TUJ1 antibody for
labeling neurons could not penetrate the tissue at tissue thicknesses
required for stereology. Instead, neurons were identiﬁed based on mor-
phological and nissl staining characteristics. With this method, we found
a 46% loss of geniculate ganglion neurons by E13.5 in bdnf−/− mice
compared to wild-type mice (pb0.05, Fig. 3B). This conﬁrms that
cells within the geniculate ganglion are lost by E13.5 of development in
Fig. 2. TUJ-1-labeled geniculate ganglia fromwild-typemice (A,C,E,G,I) were larger than those of bdnf−/−mice (B,D,F,H,J) beginning at E14.5. At E12.5, no difference was observed in
the size or appearance of the geniculate ganglion between wild-type (A) and bdnf−/− mice (B). However, beginning at E14.5, bdnf−/− geniculate ganglia (E) were smaller and
occupy fewer sections than wild-type ganglia (F). The differences between wild-type and bdnf−/− ganglia were apparent also at E16.5 (G,H) and E18.5 (I,J). The inset in panel J
represents a geniculate ganglion at higher magniﬁcation, illustrating a cell positively labeled for the neuronal marker TUJ-1, with a dark cytoplasm and a clear nucleus (marked with
an asterisk). This neuronal proﬁle was counted, while the cells around it with no clear nuclei were not quantiﬁed in this section. Scale bar in B=100 µm and applies to A–J; inset in J,
scale bar=5 µm.
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and by E18.5 there was a 65% loss in geniculate ganglion neuron number
relative to wild-type littermates (pb0.001, Fig. 3A).
Unlike neuron number, geniculate ganglion volume increasedwith
age (pb0.003, Fig. 3C). Since neuron number does not increase, this
change in volume is likely due to increases in neuron size. As with
neuron number, there was a substantial reduction in the volume of
the geniculate ganglion in bdnf−/− mice compared with wild-type
mice (pb0.001), whichwas age dependent. Speciﬁcally, therewere no
differences between the geniculate ganglion volumes of wild-type
and bdnf−/−mice at E12.5 (Fig. 3C). At E13.5 volumes weremeasured
in both the TUJ-1 labeled parafﬁn sections of the ganglia and in tissue
processed for stereology using the Cavalieri estimation. Although
not statistically signiﬁcant for parafﬁn sectioned ganglia (p=0.078),
geniculate ganglion volume was reduced by 42% in bdnf−/− mice
compared to wild-type mice (p=0.01, Fig. 3D) at E13.5, using theCavalieri estimation. Because the Cavalieri estimation requires the use
of tissue that is minimally dehydrated, estimated volumes are closer
to actual volumes. By E14.5 the geniculate ganglion from bdnf−/−
embryos was noticeably smaller (Fig. 2F), was present in fewer
sections, and had a reduced volume (pb0.05, Fig. 3C) compared to
wild-type embryos. As with neuron numbers, geniculate ganglion
volume continued to decrease relative to that of wild-types, such that
by E18.5 geniculate ganglia from bdnf−/− embryos were 80% smaller
than their wild-type counterparts (pb0.001, Fig. 2J). By E18.5
geniculate neurons were also reduced in size by 14% in bdnf−/−
embryos (118.1±4.8 μm2) relative to wild-type mice (138±3.9 μm2;
pb0.01). The parallel time courses for the reduction in volumes and
neuron number within the geniculate ganglion indicates that BDNF is
required for survival of these gustatory neurons starting early,
between E12.5 and E13.5 of development but also continues to be
required through later stages of development.
Fig. 3. Fewer neurons were present in the geniculate ganglion by E13.5 in bdnf−/−mice compared with wild-type mice. (A) Total neuron numbers at E12.5, E13.5, E14.5, E16.5, and
E18.5 in bdnf−/− and wild-type mice. The ﬁrst signiﬁcant loss in neuron number in bdnf−/− mice occurred at E13.5, and losses continued until E18.5 of development. (B) At E13,
wild-type mice also had more neurons than bdnf−/−mice when geniculate neuron number was quantiﬁed using stereology (optical fractionator). (C) The reduction in geniculate
ganglia volume in bdnf−/− mice versus wild-type mice paralleled the loss seen in neuron number. (D) The volume of the geniculate ganglion was estimated using a sterological
method (Cavalieri). *pb0.05 ,**pb0.01 and ***pb0.001.
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removal of the pro-apoptotic gene bax
We found that bdnf−/− mice lose geniculate neurons over a
protracted period of embryonic development, beginning before and
continuing beyond the period of peak cell death (Carr et al., 2005). The
loss of neurons in bdnf−/−mice could reﬂect an increased rate of cell
death, decreased proliferation rate, or both. Functional deletion of Bax
protein typically blocks apoptosis in developing sensory neurons
downstream of neurotrophic factors. To determine whether genicu-Fig. 4. The geniculate ganglion was larger in bax−/− mice than in wild-type or bdnf−/−
transverse sections through geniculate ganglia at birth. It is not possible to see individual cel
done at 100×. Geniculate ganglia from the bdnf−/− mice (B) appeared smaller than the wil
gene bax (C,D) appeared larger than wild-type or bdnf−/− ganglia. The bax−/−/bdnf−/− do
(B) are preserved in the absence of Bax. nVII indicates the facial nerve. Scale bar=100 µmlate ganglion neurons lacking the pro-apoptotic gene bax could
survive in the absence of the neurotrophin BDNF, we compared
neuron numbers using the optical dissector method for wild-type,
bdnf−/−, bax−/−, and bdnf−/−/bax−/− double knockout mice at
birth, after the period of developmental cell death has presumably
ended. Consistent with earlier ﬁndings, geniculate neuron numbers
were signiﬁcantly reduced in bdnf−/− mice compared to wild-type
mice (pb0.03, Figs. 4B and 5A). In bax−/−mice, however, there was a
doubling of both the neuronal number (pb0.01, Fig. 5A) and the
volume of the geniculate ganglion (pb0.05, Figs. 4 and 5B). Thus,mice. (A–D) Representative photomicrographs of cresyl violet-stained, 60-μm thick
ls at 20× magniﬁcation of these images due to the section thickness; quantiﬁcation was
d-type ganglia (A). In addition, geniculate ganglia from mice lacking the pro-apoptotic
uble knockout ganglion (D) was also very large, indicating that neurons lost in bdnf−/−
and applies to all panels.
Fig. 5. The bax null mutation rescued neurons from cell death in the absence of BDNF.
(A) Total number of neurons for wild-type, bdnf−/−, bax−/−, and bax−/−/bdnf−/−
geniculate ganglia. Geniculate neuron numbers were signiﬁcantly lower in bdnf−/−
mice compared to wild-type mice. In bax−/− mice, the number of geniculate neurons
doubled compared to wild-type mice, indicating that developmental cell death in the
geniculate ganglion is regulated by Bax-signaling. Neuronal number in bdnf−/−/bax−/−
double knockout mice was similar to that in bax−/− mice, indicating that Bax-null
mutations completely rescued BDNF-dependent geniculate neurons from cell death.
(B) The changes observed in total geniculate ganglion volume paralleled the changes
in neuron number, with a decrease in volume of ganglia from bdnf−/− mice, and
increase in volume of ganglia from bax−/− and bdnf−/−/bax−/− mice. *pb0.05
versus wild-type.
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ganglion neurons. This ﬁnding indicates that the pro-apoptotic gene
bax is required for naturally occurring developmental cell death of
geniculate ganglion neurons. In contrast, the bdnf−/−/bax−/− double
knockout animals had the same number of neurons as the bax−/−
mice within the geniculate ganglion (Fig. 5B). Thus, removal of bax
completely eliminated the cell loss due to the removal of BDNF. These
ﬁndings indicate that BDNF normally functions to prevent cell death
via the Bax-dependent cell death pathway.
BDNF is required for the survival of differentiated geniculate ganglion
neurons
A developing ganglion consists of an undifferentiated precursor
pool, a transient amplifying population of neuronal precursors,
mature neurons, and glia. Neurotrophins have been shown to
inﬂuence the survival of both neuronal precursors and differentiated
neurons (Ernfors, 2001; Farinas et al., 2002; Liebl et al., 2000; Lopez-
Sanchez and Frade, 2002). Here, we found that the loss of geniculate
ganglion neurons begins at E13.5 in bdnf−/− mice. Thus, we selected
this age to determine which cells are dying within the geniculate
ganglion. Cells undergoing cell death were identiﬁed using an
antibody against activated caspase-3 (Figs. 6A,D). Caspase-3 is amember of the pro-apoptotic caspase family that is synthesized as an
inactive pro-enzyme and processed to active form in cells undergoing
apoptosis. Thus, caspase-3 acts as a relevant marker for developmen-
tal cell death (De Zio et al., 2005). We quantiﬁed the number of
precursors using BrdU, a cell proliferation marker (Figs. 6B,E).
Differentiated neurons were enumerated using an antibody against
neuroﬁlament (Figs. 6C,F), an intermediate ﬁlament found speciﬁcally
in neurons (Debus et al., 1982; Shaw et al., 1984). Differentiated
neurons undergoing cell death were labeled by antibodies to both
activated caspase-3 and neuroﬁlament (Figs. 6G,H,I). In the absence of
BDNF, a 65% increase in geniculate ganglion cells positively labeled for
activated caspase-3 was observed (pb0.01, Fig. 7). These observations
are consistent with an increase in activated caspase-3-dependent cell
death in bdnf−/−mice at E13.5. No signiﬁcant difference was seen for
the number of BrdU positive cells in bdnf−/− versus wild-type
embryos (Fig. 7). Also, no cells were co-labeled for neuroﬁlament and
BrdU in either wild-type or bdnf−/− mice, this ﬁnding indicates that
neurons that express neuroﬁlament have exited the cell cycle phase of
development. In addition, we found no neurons that were co-labeled
with either caspase-3 or BrdU, indicating that proliferating cells are
not dying in either wild-type or bdnf−/−mice. This implies that BDNF
does not inﬂuence the dividing geniculate cell population during
development. On the other hand, the number of double-labeled
cells for activated caspase-3 and neuroﬁlament increased by 6-fold
in bdnf−/− as compared to wild-type ganglia cells (pb0.01, Fig. 7).
This ﬁnding indicates that BDNF is required for survival of
differentiated geniculate ganglion neurons. We did not observe
cells labeled for all the three antigens.
At E13.5, BDNF is expressed primarily by the peripheral targets of
geniculate neurons
Geniculate ganglion neuron loss begins at E13.5, suggesting that
the presence of BDNF in the gustatory system is essential beginning at
this early embryonic age. Several sources may provide the BDNF
necessary for survival of geniculate neurons at E13.5. Neurotrophins
are frequently produced by peripheral targets in minimal amounts to
enable survival of correctly wired neurons (Huang and Reichardt,
2001; Vogel and Davies, 1991). However, neurotrophins are also
producedwithin sensory ganglia as well as along projection pathways
(Farinas et al., 1996). To identify the source of BDNF at E13.5, we used
genetically engineered mice with a lacZ reporter gene inserted in
place of BDNF in one allele (Yee et al., 2003). Thus, the pattern of β-Gal
acted as a visible reporter for endogenous BDNF expression. The
geniculate ganglion showed only tiny spots of β-Gal reaction product
(Fig. 8B), indicating that overall BDNF expression was not robust
(Fig. 8A).
Geniculate ganglion neurons innervate three targets: taste buds on
the palate (soft palate and nasoincisor ducts), taste buds of the
tongue, and skin of the external ear. The developing palatal shelves
did not show any apparentβ-Gal staining at E13.5within either whole
mount (Fig. 8C) or coronal sections (Fig. 8D). Thus, the developing soft
palate is not a primary source of BDNF for developing geniculate
neurons at E13.5. In the lingual epithelium, the developing fungiform
placodes, where taste buds will eventually develop, showed intense
β-Gal staining, demonstrating robust BDNF expression, speciﬁcally in
the fungiform placodes (Fig. 9C). Note that the epithelium surround-
ing the fungiform placodes is completely devoid of any β-Gal staining.
Furthermore, the intense β-Gal staining present in the placode
appears to be limited to the epithelium (Fig. 9C, arrowheads indicated
epithelial mesenchyme border). In the sagittal sections of the tongue,
diffuse β-Gal staining was visible in the base, where the nerve enters
(Figs. 9D,F). The mesenchyme surrounding the peripheral sensory
ﬁber bundles also showed diffuse β-Gal spots, seen clearly in blue
(Fig. 9E). BDNF expression within the tongue epithelium is limited to
the gustatory targets. Although the gustatory ﬁbers have not invaded
Fig. 6. More neuronal cells contained activated caspase-3 in bdnf−/− than wild-type ganglia at E13.5. Triple immune-ﬂuorescence labeling was used to identify dying cells (BLUE:
rabbit polyclonal anti-activated caspase-3, “AC-3”), dividing cells (green: rat monoclonal anti-BrdU, “BrdU”), and differentiated neurons (red: anti-neuroﬁlament, “NF”) in
the developing geniculate ganglion of wild-type (A–C) and bdnf−/− (D–F) mice at E13.5. Several cells were positively labeled for the cell deathmarker, AC-3 (A,D). Cells labeled with
AC-3 tended to be small and irregularly shaped. In some instances, a single cell appeared as multiple apoptotic vesicles. We observed more double-labeled cells for AC-3 and NF in
bdnf−/− (white arrowheads in F) than in wild-type ganglia (arrowheads in C). There was no co-localization between BrdU and AC-3, indicating that precursors are not dying in the
bdnf−/−mice. There were also no differentiated neuronal cells that were still dividing. A high magniﬁcation image of two cells double-labeled for NF and AC-3 and one cell labeled
only for AC-3 (arrowhead) is shown at themagniﬁcation used for counting (arrows in G, H, I). Scale bar in F=50 µm and applies to A–E; scale bar in I=20 µm and applies to G and H.
425A.V. Patel, R.F. Krimm / Developmental Biology 340 (2010) 419–429the epithelium at E13.5 (Figs. 9G,H), the ﬁbers have just reached the
fungiform placodes and are in a position to detect the BDNF produced
there. The external ear also showed substantial amounts of β-Gal
staining (Figs. 9I,J), indicating that this target also expresses BDNF.
The central branches of geniculate neurons project to the nucleus
of the solitary tract in the brainstem. We did not observe β-GalFig. 7.More differentiated neurons were dying in bdnf−/−mice than in wild-type mice
at E13.5. The number of geniculate ganglion cells positively labeled for activated
caspase-3 (AC-3), BrdU, and double-labeled for neuroﬁlament (NF)/AC-3 was plotted
for wild-type (n=3) and bdnf−/− (n=3) embryos. Cells that were positively labeled
for AC-3 increased signiﬁcantly in BDNF-null mice. On the other hand, no signiﬁcant
difference was observed in the number of BrdU labeled cells between wild-type and
bdnf−/− ganglia. Bdnf−/− mice showed a 6-fold increase in differentiated neurons
labeled for the cell death marker AC-3. Thus, the number of neurons dying in bdnf−/−
mice was six times more than in wild-type animals, indicating that BDNF is required for
the survival of differentiated geniculate ganglion neurons. * indicates differences from
wild-types at pb0.05.staining in the brainstem at E13.5 (data not shown). Of the tissues
examined, the two most robust sources of BDNF were the fungiform
papillae and the external ear. While this does not exclude BDNF from
other sources, our results indicate that the primary sources of BDNF at
E13.5, when geniculate neurons are ﬁrst BDNF-dependent, are the
peripheral targets of these neurons.
Discussion
Peripheral developing ganglia are formed by the migration of
neural crest-derived or placodal-derived progenitor cells that under-
go several cell cycles, resulting in an over production of neurons,
which are then reduced in number via cell death. Neurotrophins could
potentially inﬂuence total neuron number by regulating various
stages of this process. The timing of neuron loss in neurotrophin null
mice indicates a great deal about their function. For example, neurons
in the DRG of nt-3−/−mice are ﬁrst lost between E11 and E13, which
is well before target innervation (Farinas et al., 1996). Alternatively,
in ngf−/− mice, DRG neurons are ﬁrst lost between E13.5 and E15.5
(White et al., 1996). Therefore, NGF may function purely as a target-
derived neurotrophic factor in this system, while NT3 cannot. BDNF is
required to maintain embryonic geniculate neuron number in vivo
and in vitro (Al-Hadlaq et al., 2003; Conover et al., 1995). Here, we
demonstrate that in the absence of BDNF, the geniculate ganglion
initially loses 46% of its cells by E13.5. This loss occurs just as fun-
giform placodes/papillae are starting to become innervated. The
tongue fungiform papillae, which eventually house taste buds,
become innervated between E13.5 and E14.5, and directed growth
by the chorda tympani toward these papillae has been observed by
E13.5 (Mbiene, 2004). Consistent with these studies, we also observed
that many chorda tympani ﬁbers end just below the epithelial surface
by E13.5. In addition, removal of BDNF from the epithelium on or
before E13.5 disrupts target innervation, while removal of BDNF after
E14.5 does not (Ma et al., 2009). Taken together these ﬁndings indi-
cate that geniculate neurons are ﬁrst lost in bdnf−/− mice as chorda
Fig. 8.Neither the developing geniculate ganglion nor the soft palate showed signiﬁcant BDNFLacZ expression at E13.5. The geniculate ganglion was identiﬁed in sagittal sections of an
E13.5 bdnf LacZ mouse embryo head following staining for anti-neuroﬁlament (brown) and β-Gal (blue). (A) β-Gal could not be seen at low magniﬁcations. (B) At a higher
magniﬁcation of the geniculate ganglion, speckled expression of β-Gal was clearly observed as azure colored dotted (black arrows). (C)Wholemount β-Gal staining of the soft palate
revealed no β-Gal positive areas in the developing soft palate (arrows). However, glandular tissue immediately lateral and rostral to the developing soft palate appeared to be stained
(arrowheads). (D) Coronal section through the mouse head conﬁrmed the absence of β-Gal expression in the developing soft palate (arrows). Scale bar in A=100 μm; B=10 μm;
C=500 μm and D=200 μm.
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their targets. This is likely the earliest age at which BDNF expressed
by the gustatory placodes could inﬂuence chorda tympani neuron
development.
While the timing of neuron loss is consistent with a target-derived
neurotrophic factor role for BDNF in the taste system, it occurs much
earlier thanmight be expected based on studies of normally occurring
cell death in this system. In rat, naturally occurring cell death peaks at
later embryonic stages (Carr et al., 2005) and occurs concurrently
with a decrease in BDNF expression within the fungiform papillae
(Nosrat and Olson, 1995). We observed a loss of geniculate neurons in
wild-type mice by E16.5, consistent with a peak cell death between
E14.5 and E16.5 in the mouse. Therefore, geniculate neurons become
BDNF-dependent as they innervate their targets, but before naturally
occurring developmental cell death. BDNF also regulates neuron loss
in the geniculate ganglion earlier than other BDNF-dependent sensory
systems. The initial vestibular and visceral BDNF-dependent sensory
neuron loss occurs well after, rather than concurrent with, target
innervation in bdnf−/−mice (Brady et al., 1999; ElShamy and Ernfors,
1997; Erickson et al., 2001; Ernfors, 2001). Therefore, the timing
between onset of BDNF dependence and target innervation seems to
vary among different BDNF-dependent sensory neuron populations.
Although the ﬁrst major loss of geniculate ganglion neurons is
observed at E13.5 in BDNF-null mice, this loss continues to increase
until E18.5, when 65% fewer neurons exist in bdnf−/− mice than in
wild-type littermates. Thus, neuron loss continues at a greater rate in
bdnf−/− mice than in wild-type mice throughout the normal period
of geniculate ganglion cell death (Carr et al., 2005). The soft palate is
innervated 1 day later than the tongue, at E15.5 (Nakayama et al.,
2008). Therefore, neurons innervating the soft palate may be initially
lost after E13.5, contributing to the later neuronal losses. In addition,
the continued loss of neurons in bdnf−/− ganglia is consistent with
late postnatal loss of chorda tympani ﬁbers from the tongue. In the
BDNF-null animals, targeting is disrupted, and chorda tympani ﬁbers
branch extensively near the epithelial surface (Ma et al., 2009). By
E18.5, some of these ﬁbers innervate the correct target, but most
withdraw. This loss of peripheral innervation occurs between E16.5and E18.5, corresponding to the later neuronal losses observed in
bdnf−/−mice. Thus, the continued loss of geniculate ganglion neurons
after E13.5 in the absence of BDNF could be explained, in part, by the
difference in timing of innervation to the tongue and soft palate. In
addition, this continued neuron loss explains the relatively late
withdrawal of afferent ﬁbers innervating the tongue in bdnf−/−mice.
Developmental neuronal death has been attributed to a Bax-
dependent programmed cell death pathway (White et al., 1998). Bax
is a member of the Bcl-2 family of proteins that play key roles in
programmed cell death via the intrinsic or mitochondrial pathway.
We found that normal developmental cell death in the geniculate
ganglion requires Bax. Furthermore, we demonstrated that Bax
removal rescues neuron losses in BDNF-null mice demonstrating
that BDNF can only regulate geniculate neuron number when Bax is
also present. Thus, BDNF enables survival in this ganglion by
suppressing the Bax-dependent cell death pathway. This ﬁnding is
consistent with previous demonstrations that Bax-null mutation
rescues BDNF-dependent neuronal loss in the developing nodose-
petrosal ganglion as well as in the visceral ganglion (Hellard et al.,
2004). Other neurotrophins have also been shown to inhibit the Bax-
dependent cell death pathway to allow neuron survival. NGF- and NT-
3-dependant spinal sensory neuron loss can be rescued via inhibition
of the Bax-dependent cell death pathway (Patel et al., 2000, 2003).
Thus, inhibition of the Bax-dependent cell death pathway is a
common mechanism employed by neurotrophins to support survival
of developing sensory neuronal populations.
While both Bax inhibition and caspase-3 activation are common
mechanisms of neurotrophin action, neither is universal. Death in
different neuronal types might result from the activation of varying
arrays of caspases, activation of these molecules commonly results in
caspase-3 activation for many neurons (Yuan and Yankner, 2000).
Caspase-3 typically functions downstream of Bax and cleaves dif-
ferent substrates to facilitate cell death via DNA fragmentation (De Zio
et al., 2005; Earnshaw et al., 1999). Geniculate ganglia from bdnf−/−
mice had a higher number of neurons expressing activated caspase-3
than wild-type mice. Thus, BDNF prevents neuron death through a
caspase-3 dependent mechanism. Interestingly, caspase-3 is also
Fig. 9. Robust β-Gal staining was observed in the developing tongue fungiform placodes and the outer ear at E13.5. (A) A whole mount tongue contained dark β-Gal staining, seen as
blue spots, corresponding to the locations of fungiform placodes in the front two-thirds of the tongue. A larger blue spot (arrowhead) in the caudal part of the tongue was in the
location of the circumvallate papillae. (B) Sagittal sections through an E13.5 tongue stained for β-Gal showed dark blue labeling (arrowheads). The area within the box in (B) is
presented at higher magniﬁcation in (C). The intense blue staining in the placodes appeared to be limited to epithelium (arrowheads indicate the epithelial/mesenchyme border).
The epithelium surrounding the fungiform papillae was entirely devoid of any β-Gal staining, but the fungiform placodes were stained bright blue, indicating intense BDNF-LacZ
expression in the fungiform placodes at this age. (D) Sagittal section through a different E13.5 tongue, stained for β-Gal and sequentially immuno-labeled for anti-neuroﬁlament
showed a dark brown-labeled nerve entering via the base of the tongue and nerve ﬁbers and extending toward the epithelium. (E) A high magniﬁcation image of the base of the
tongue outlined by a black box in (D), shows tiny blue spots that represent β-Gal staining at the point where the peripheral nerve enters the tongue. (F) A higher magniﬁcation image
of a different region of same tongue (pink box in D) shows peripheral sensory ﬁbers traversing the mesenchymal tissue surrounded by some speckled β-Gal staining. This image
illustrates that some BDNF is expressed in the tongue mesenchymal tissue surrounding the nerve ﬁbers. (G,H) Immuno-ﬂuorescent images of a sagittal E13.5 tongue section
illustrates the relationship between the nerve ﬁbers (anti-neuroﬁlament, red) and the epithelium (DAPI, blue). Many peripheral nerve projections had reached, but have not yet
penetrated the epithelium, by E13.5 (G). The boxed area is shown at higher magniﬁcation in (H). (I) The outer ear was heavily stained at E13.5 in whole mounts (arrowhead). (J) A
transverse section (arrow) illustrates ample expression of the BDNF-LacZ in the outer ear, the third target of geniculate ganglion neurons. Scale bar in A and I=500 μm; B, G, and
J=100 μm; C, E, and F=10 μm; D=100 μm; H=50 μm.
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opmental cell death is mediated by the same mechanisms as BDNF
deﬁciencies.
The stage of development at which neurons die in neurotrophin
mutants varies across sensory neuron populations and neurotrophins.
We found that proliferating cells (precursors) in the geniculate ganglion
were unaffected by BDNF removal and that no precursor cells also
contained activated caspase 3 in either wild-type or bdnf−/−mice. This
is very different from the DRG, where NT-3 has been shown to regulate
the precursor population (Elshamy and Ernfors, 1996; Farinas et al.,
2002, 1996). BDNF removal increased activated caspase 3 speciﬁcally
with in cells that also expressed neuroﬁlament. Neuroﬁlaments are
typically expressed in differentiated neurons, but can also be expressed
in late stage neuronal precursors (Hall and Landis, 1991; Tapscott et al.,
1981). However, we found no cells positively labeled with neuroﬁla-
ment and BrdU, indicating that neuroﬁlament positive precursors
were either non-existent or so fewas to remainundetected. It is possible
that the presence or absence of neuroﬁlament positive neuronal
precursors depends on neuron location and age. Regardless, we did
not see any neuroﬁlament positive cells that were also proliferating in
the geniculate ganglion at E13.5. Thus, it appears that it is largelydifferentiated neuronsundergoing increased cell death in the geniculate
ganglion in response to BDNF removal. BDNF may function similarly in
other BDNF-dependent sensory populations (Brady et al., 1999;
ElShamy and Ernfors, 1997; Erickson et al., 2001; Ernfors, 2001);
however, geniculate neurons are the ﬁrst BDNF-dependent sensory
population in which neuron proliferation and death have been spe-
ciﬁcally examined.
Because differentiated geniculate neurons require BDNF for sur-
vival beginning at E13.5, we examined the possible sources of BDNF
available to geniculate neurons at this age. It is well established that
BDNF is expressed in developing fungiform papillae and in the soft
palate during embryonic rat development (Nosrat, 1998; Nosrat et al.,
1996; Nosrat and Olson, 1995), and also in developing rat geniculate
ganglia (Schecterson and Bothwell, 1992). Similar to rat (Nosrat and
Olson, 1995), we show that at E13.5 the developing fungiform papillae
in the mouse tongue are a major source of BDNF. Another target of
geniculate neurons, the external ear, also appears to be a primary
source of BDNF for developing geniculate neurons at E13.5. Interest-
ingly, BDNF expression is not robust in the soft palate at E13.5. This
subpopulation of geniculate neurons may not be dependent on BDNF.
Roughly, one-third of the geniculate neurons innervate each of the
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et al., 1984), therefore, it is certainly possible that themissing neurons
only innervate tongue and the external ear. More likely, BDNF
expression may be initiated and may support neuron survival at
later stages of development than for the front two-thirds of the
tongue, because target innervation occurs later in the soft palate than
in the tongue. The base of the tongue and the geniculate ganglion
produced relatively small amounts of BDNF. In addition to being
sparse, the β-Gal-reaction is very punctate which could represent the
degradation of the beta-gal protein in contrast to the cytoplasmic
labeling characteristic of cells actively synthesizing beta-galactosi-
dase. This would imply that while these cells did synthesize beta-gal
and therefore BDNF at previous stages of development, they are no
longer actively producing protein at E13.5. We did not observe BDNF-
lacZ expression in the hindbrain at E13.5. Therefore, BDNF in these
locations is less likely to contribute to geniculate neuron survival at
E13.5 than BDNF in the target. This hypothesis is consistent with our
observations that neurons survive independently of BDNF until their
axons near their peripheral targets, indicating that BDNF produced
along the path of innervation is not essential for survival of these
neurons. Thus, the robust expression of BDNF in the developing
fungiform papillae and outer ear at the time point of initial neuron
loss indicates that BDNF produced by the terminal targets is essential
for survival of these neurons.
Our ﬁndings indicate that during normal development, geniculate
ganglion neurons differentiate and extend axons to innervate the
tongue independently of BDNF. By E13.5, these axons approach the
developing fungiform papillae and the developing ear, where robust
levels of BDNF are produced. At this time, developing geniculate
neurons become dependent on BDNF for survival. BDNF expressed in
fungiform papillae or in the external ear suppresses the death of
differentiated geniculate ganglion neurons by inhibiting the activa-
tion of Bax and caspase-3. At later embryonic ages, BDNF expression in
the fungiform papillae decreases (Nosrat and Olson, 1995), resulting
in neuronal death by the activation of both Bax and caspase-3.Acknowledgments
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